Covered recipient · General Payments record
KELLY NICOLE LENHART
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$1,571.30
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $414.70 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $141.31 | 7 |
| AIMMUNE THERAPEUTICS, INC. | $97.94 | 1 |
| Celgene Corporation | $34.83 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.86 | 1 |
| Regeneron Healthcare Solutions, Inc. | $23.64 | 1 |
| Merck Sharp & Dohme Corporation | $22.70 | 1 |
| PFIZER INC. | $22.41 | 1 |
| Janssen Biotech, Inc. | $21.56 | 1 |
| VIVUS LLC | $16.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.75 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107528765 | CMS |
| ABBVIE INC. | $21.06 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107528767 | CMS |
| ABBVIE INC. | $8.54 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107528769 | CMS |
| ABBVIE INC. | $24.24 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107528771 | CMS |
| ABBVIE INC. | $13.78 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107528773 | CMS |
| ABBVIE INC. | $20.19 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107528775 | CMS |
| ABBVIE INC. | $37.75 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107528777 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $97.94 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146964822 | CMS |
| Celgene Corporation | $19.78 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101191407 | CMS |
| Celgene Corporation | $15.05 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101191411 | CMS |
| Janssen Biotech, Inc. | $21.56 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078742209 | CMS |
| Merck Sharp & Dohme LLC | $22.70 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141808385 | CMS |
| PFIZER INC. | $22.41 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132041027 | CMS |
| Regeneron Healthcare Solutions, Inc. | $23.64 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114332049 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.86 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137780914 | CMS |
| VIVUS LLC | $16.45 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129420323 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.